계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
InoCardia
About
InoCardia has developed the ‘work-loop’ model as a pre-clinical myocardial assay assessing cardiac contractility.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- £229K
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Inocardia is a Coventry University spinout focused on the provision of Contract Research Services via the development of assays targeted at the biotech and pharmaceutical sectors. Inocardia has developed the ‘work-loop’ model as a pre-clinical myocardial assay assessing cardiac contractility in normal, diseased and ageing myocardium in order to determine the cardiovascular safety of lead pharmaceutical compounds. The Coventry University work-loop assay is the only relevant in-vitro human model of cardio-toxicity available worldwide. Both the pharmaceutical industry and regulators recognise that contractility assessment is currently fraught with problems.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 21, 2014 | Series Unknown | £229K | 1 |
Mercia Fund Managers
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mercia Fund Managers
|
Yes | Series Unknown |
